The potential for STAT5 as a biomarker in breast cancer has been previously suggested [51,52], but further research needs to be conducted to fully elucidate how STAT5 can act as both a tumor promoter and tumor suppressor in various subtypes of breast cancer. This evidence concerns the gene STAT5B and breast carcinoma.